EVALUATION OF THE RESULTS OF THE EFFECTIVENESS OF CRANIOCEREBRAL HYPOTHERMIA AS PART OF COMPLEX TREATMENT IN PATIENTS WITH SEVERE TRAUMATIC BRAIN INJURY

The study is based on the analysis of 387 medical records of inpatients with severe traumatic brain injury. The objective of the study was to evaluate the effectiveness of CCH as part of the complex treatment of patients with brain compression by epidural hematoma after surgery, depending on the timing of its use from the moment of injury. The criterion for evaluating the results was the percentage of patient mortality in clinical groups. It has been proven that the effectiveness of CCH as part of complex treatment depends on the timing of its use from the moment of exposure to the traumatic factor. It was found that the use of CCH in the first 48 hours from the moment of injury reduces mortality, while its use after 48 hours after exposure to the traumatic factor does not affect the mortality rate in victims with severe TBI.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-07-15
DOI
https://doi.org/10.5281/zenodo.15914953
Primary Topic
Traumatic Brain Injury and Neurovascular Disturbances
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

EVALUATION OF THE RESULTS OF THE EFFECTIVENESS OF CRANIOCEREBRAL HYPOTHERMIA AS PART OF COMPLEX TREATMENT IN PATIENTS WITH SEVERE TRAUMATIC BRAIN INJURY

Zenodo (CERN European Organization for Nuclear Research)
Traumatic Brain Injury and Neurovascular Disturbances
article

EVALUATION OF THE RESULTS OF THE EFFECTIVENESS OF CRANIOCEREBRAL HYPOTHERMIA AS PART OF COMPLEX TREATMENT IN PATIENTS WITH SEVERE TRAUMATIC BRAIN INJURY

article en

Abstract

The study is based on the analysis of 387 medical records of inpatients with severe traumatic brain injury. The objective of the study was to evaluate the effectiveness of CCH as part of the complex treatment of patients with brain compression by epidural hematoma after surgery, depending on the timing of its use from the moment of injury. The criterion for evaluating the results was the percentage of patient mortality in clinical groups. It has been proven that the effectiveness of CCH as part of complex treatment depends on the timing of its use from the moment of exposure to the traumatic factor. It was found that the use of CCH in the first 48 hours from the moment of injury reduces mortality, while its use after 48 hours after exposure to the traumatic factor does not affect the mortality rate in victims with severe TBI.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 40%
Traumatic Brain Injury and Neurovascular Disturbances
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.